Regeneron Pharmaceuticals Stock Pattern Recognition Harami Pattern
| REGN Stock | USD 749.05 2.08 0.28% |
| Symbol |
Recognition |
The output start index for this execution was eleven with a total number of output elements of fifty. The function generated a total of three valid pattern recognition events for the selected time horizon. The Harami pattern describes bullish reversal trend for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals Technical Analysis Modules
Most technical analysis of Regeneron Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Regeneron from various momentum indicators to cycle indicators. When you analyze Regeneron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Regeneron Pharmaceuticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Regeneron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regeneron Pharmaceuticals's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Regeneron Pharmaceuticals, we also check how macroeconomic factors affect Regeneron Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 157.7 | 159.65 | 143.68 | 76.28 | PTB Ratio | 3.61 | 2.62 | 2.36 | 2.24 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Will Biotechnology sector continue expanding? Could Regeneron diversify its offerings? Factors like these will boost the valuation of Regeneron Pharmaceuticals. Anticipated expansion of Regeneron directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Regeneron Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.18 | Dividend Share 2.64 | Earnings Share 41.69 | Revenue Per Share | Quarterly Revenue Growth 0.009 |
Investors evaluate Regeneron Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Regeneron Pharmaceuticals' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Regeneron Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Regeneron Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Regeneron Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Regeneron Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.